Health Hub Roden
Polyganics is a medical technology company with multiple versatile polymer platforms. The Company develops, manufactures and commercializes innovative bioresorbable medical devices that facilitate tissue repair and regeneration.
Polyganics’ portfolio includes products developed in-house and in collaboration with leading medical technology companies and academic centers of excellence. In the Peripheral Nerve Repair (PNR) field, the portfolio includes three marketed products: VIVOSORB® for minimizing unwanted tissue adhesions after surgery; NEUROLAC® for supporting PNR following hand surgery; and NEUROCAP® for the management of symptomatic neuromas. In the Neurosurgery and General Surgery field, products in development include a sealant for the dura membrane (LIQOSEAL®) and a liver and pancreas sealant patch.
In 2014, Polyganics sold its Ear, Nose & Throat (ENT) surgery business unit (the Nasopore® product family including Hemopore®, Sinupore®, Otopore® and Nasopore-FD®) to Stryker, one of the world’s leading medical technology companies. Polyganics continues to manufacture the Nasopore® product range for Stryker. To date, Polyganics has produced and delivered more than 4.5 m devices.
Polyganics is profitable and privately held. The Company is based in Groningen, The Netherlands, a center of biomedical engineering excellence, in an ISO 13485-certified manufacturing facility. The Company’s polymer platform technologies are protected by a broad portfolio of patents and its products have received clearance from the US FDA, CE-approval, and approval from CFDA and other international authorities. For more information, visit: www.polyganics.com
UMCG Transplant Centre
Within the UMCG Transplant Centre all possible types of organ transplantation are carried out. In the fields of kidney, liver, lung, heart, small intestine, stem cell and cornea transplantation the UMCG has gained profound expertise.
The UMCG Transplant Centre is in a constant state of change, innovating to uphold the highest levels of knowledge and expertise.
UMCG Transplant Centre – An introduction All transplant programs in the UMCG cooperate through the umbrella organisation of the UMCG Transplant Centre. Each transplant program; however, remains independent and its own entity. That being said many similarities remain. The programs reinforce each other in these and overlapping areas by combining knowledge and experience. Examples of this include post-transplant care, joint lines of research and centre-oriented education. The motto of the UMCG Transplant Centre sums up this collaboration as: ‘Shared care for shared organs®’.
Patient Care Independent of the organ transplanted, a transplant patient will receive care from many different disciplines in the outpatient setting, both pre- and post-transplant. Examples include the nurse specialist, dietician, physiotherapist, dermatologist and endocrinologist. Almost all patients will receive care from these disciplines at some point during their transplant process.
Developments in Patient Care Through the means of a multidisciplinary transplantation outpatient clinic the most appropriate care is offered to transplant patients. Secondly, the first results of a multidisciplinary rehabilitation programme at the UMCG Beatrixoord proved to be successful. This programme will be continued and also an outpatient lifestyle clinic has been established. Furthermore, the Organ Preservation and Resuscitation (OPR) unit is a facility that aims to increase the quality of donor organs, resulting in more patient’s organs being successfully transplanted.
Research Constant improvement is crucial to ensure the highest standard of care for patients. Therefore, the UMCG Transplant Centre has a wide range of research initiatives. On the one hand this research focuses on improving the care for donors and their next of kin. While on the other hand extensive research is conducted in the field of improving the quality of donor organs, known as organ preservation. A biobank for transplant patients, called Transplantlines, has been conducted. The extensive cohort of Transplantlines supports the long-term follow-up in healthy aging. The UMCG Transplant Research Fund provides financial assistance for small and/or high risk research projects experiencing difficulty securing funds through other means.
Education and Training The UMCG Transplant Centre aims to provide high quality patient care and world class research which requires highly qualified professionals and an inspiring work environment. Therefore, modern education and training facilities are of the utmost importance. Just like patient care and research, education is also co-ordinated by the UMCG transplant centre. The UMCG Transplant centre aims to create an efficient and high-quality training ‘climate’ to facilitate education both internally and externally.